Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Long-Term Effects of Sublingual Grass Therapy [Phase 2]
Phase 2 trial evaluating the long-term safety and effects of sublingual grass pollen immunotherapy for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine [Phase 1]
A Phase 1 study assessing the relative bioavailability of intranasal fluticasone furoate and levocabastine has been completed. The trial inv…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 randomized, double-blind, parallel-group, placebo-controlled trial evaluating cetirizine HCl syrup and loratadine syrup against plac…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) [Phase 3]
Phase 3 safety and efficacy trial of epinastine nasal spray in seasonal allergic rhinitis completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance [Phase 2]
This update reports the completion of a Phase 2 study evaluating VAK694 in combination with allergen immunotherapy to induce specific immune…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit [NA]
Completed clinical trial evaluating pollen starch granules in pollen challenge studies at the Fraunhofer Environmental Exposure Unit for ast…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis [Phase 1, Phase 2]
Phase 1/2 trial evaluating Nasapaque Nasal Solution for efficacy and safety in adults with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial update on a once-daily investigational nasal spray for seasonal allergic rhinitis in adults and adolescents; the study has com…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen
A completed clinical trial from Universität des Saarlandes evaluating quality of life in patients with seasonal allergic rhinitis treated wi…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602) [Phase 2]
A Phase 2 dose-ranging trial evaluating the efficacy and safety of ciclesonide HFA nasal aerosol in adults and adolescents 12 years and olde…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
Clinical trial update on the efficacy, safety, and tolerability of a 4-week regimen of ciclesonide nasal spray (200 mcg) for intermittent an…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406) [Phase 3]
Phase 3 study using an environmental exposure chamber to assess the onset of action of ciclesonide nasal spray for seasonal allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407) [Phase 3]
A Phase 3 trial evaluating onset of action of ciclesonide nasal spray for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]
A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413) [Phase 3]
A Phase 3 clinical trial update reporting completion of a study evaluating ciclesonide nasal spray in adults with seasonal allergic rhinitis…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417) [Phase 3]
Phase 3 study assessing the safety and efficacy of ciclesonide in pediatric patients (6-11 years) with seasonal allergic rhinitis. The trial…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber [Phase 2]
A Phase 2 study comparing QAV680 to placebo for seasonal allergic rhinitis in an environmental exposure chamber, with the trial status liste…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo [Phase 2]
A Phase 2 trial evaluating a single-dose oral GSK835726 compared with placebo in seasonal allergic rhinitis has completed, using an allergen…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR) [Phase 2]
A Phase II study evaluating intranasal GSK256066 in combination with fluticasone propionate for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ciclesonide nasal spray in participants with seasonal allergic rhinitis in Russia. The s…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]
Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has c…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action [Phase 3]
A Phase 3 trial in adolescents and adults 12 years and older with seasonal allergic rhinitis to assess onset of action has been completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Seasonal Allergic Rhinitis In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial update for seasonal and perennial allergic rhinitis sponsored by GlaxoSmithKline; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis. [Phase 3]
Phase 3 clinical trial update for adults and adolescents with seasonal allergic rhinitis, sponsored by GlaxoSmithKline (NCT00225823).
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis has completed.